Atraumatic fractures in heart failure

American Journal of the Medical Sciences

Volumn 338, Issue 1, 2009, Pages 45-47

  Raza, Syed H ^a   Law, Peter ^a   Farooqui, Nabeel ^a   Carbone, Laura D ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fractures; Heart failure

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; FARNESYL DIPHOSPHATE; FUROSEMIDE; GERANYLGERANYL PYROPHOSPHATE; INTERLEUKIN 6; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

BODY WEIGHT; BONE DENSITY; CALCIUM EXCRETION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CIGARETTE SMOKING; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; FATIGUE; FRAGILITY FRACTURE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERALDOSTERONISM; KIDNEY DISEASE; MENOPAUSE; ORTHOSTATIC HYPOTENSION; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; WEIGHT REDUCTION; AGED; FRACTURE; PATHOLOGY; REVIEW; RISK FACTOR;

AGED; FRACTURES, BONE; HEART FAILURE; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 68849117094     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181aaefc1     Document Type: Conference Paper

References (43)

1. Keen RW. Burden of osteoporosis and fractures. Curr Osteoporos Rep 2003;1:66-70.
2. Jiang HX, Majumdar SR, Dick DA, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 2005;20:494-500.
3. Aronow WS. Heart disease and aging. Med Clin North Am 2006;90: 849-862
4. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-957
5. Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility. J Gerontol A Biol Sci Med Sci 2002;57: M45-46.
6. Kenny AM, Boxer R, Walsh S, et al. Femoral bone mineral density in patients with heart failure. Osteoporos Int 2006;17:1420-1427
7. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207.
8. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008;358:1474-1482
9. Farhat GN, Newman AB, Sutton-Tyrrell K, et al. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int 2007;18:999-1008.
10. Sennerby U, Farahmand B, Ahlbom A, et al. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 2007;18:1355-1362
11. van Diepen S, Majumdar SR, Bakal JA, et al. Heart failure is a risk factor for orthopedic fracture: A population-based analysis of 16,294 patients. Circulation 2008;118:1946-1952
12. Krum H, Abraham WT. Heart failure. Lancet 2009;373:941-955
13. Qaseem A, Snow V, Shekelle P, et al. Screening for osteoporosis in men: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2008;148:680-684 (Pubitemid 351669113)
14. Tanko LB, Christiansen C, Cox DA, et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005;20:1912-1920
15. http://drugtopics.modernmedicine.com.
16. Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Intern Med 2006;259:117-124
17. Cumming RG, Miller JP, Kelsey JL, et al. Medications and multiple falls in elderly people: The St Louis OASIS study. Age Ageing 1991; 20:455-461
18. Law PH, Sun Y, Bhattacharya SK, et al. Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 2005;46:142-146
19. Lim LS, Fink HA, Kuskowski MA, et al. Loop diuretic use and increased rates of hip bone loss in older men: The Osteoporotic Fractures in Men Study. Arch Intern Med 2008;168:735-740
20. Carbone LD, Johnson KC, Bush AJ, et al. Loop diuretic use and fracture in postmenopausal women: Findings from the Women's Health Initiative. Arch Intern Med 2009;169:132-140
21. Bolland MJ, Ames RW, Horne AM, et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 2007;18:479-486
22. Chhokar VS, Sun Y, Bhattacharya SK, et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871-878
23. Kitchin B, Morgan SL. Not just calcium and vitamin D: Other nutritional considerations in osteoporosis. Curr Rheumatol Rep 2007; 9:85-92.
24. Carbone LD, Cross JD, Raza SH, et al. Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 2008;52:135-138
25. Ramasubbu K, Estep J, White DL, et al. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:415-426
26. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949
27. Nguyen ND, Wang CY, Eisman JA, et al. On the association between statin and fracture: A Bayesian consideration. Bone 2007;40:813-820
28. LaCroix AZ, Cauley JA, Pettinger M, et al. Statin use, clinical fracture, and bone density in postmenopausal women: Results from the Women's Health Initiative Observational Study. Ann Intern Med 2003;139:97-104.
29. van Staa TP, Wegman S, de Vries F, et al. Use of statins and risk of fractures. JAMA 2001;285:1850-1855
30. Cherruau M, Facchinetti P, Baroukh B, et al. Chemical sympathectomy impairs bone resorption in rats: A role for the sympathetic system on bone metabolism. Bone 1999;25:545-551
31. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000;100:197-207.
32. Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111:305-317
33. Moore RE, Smith CK II, Balley CS, et al. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 1993;23:301-315
34. Schlienger RG, Kraenzlin ME, Jick SS, et al. Use of beta-blockers and risk of fractures. JAMA 2004;292:1326-1332
35. Fried LP, Varadhan R, Bohr VA. Opinion section on frailty. Mech Ageing Dev 2008;129:665.
36. Baldini V, Mastropasqua M, Francucci CM, et al. Cardiovascular disease and osteoporosis. J Endocrinol Invest 2005;28:69-72.
37. Gardner MJ, Demetrakopoulos D, Shindle MK, et al. Osteoporosis and skeletal fractures. HSS J 2006;2:62-69
38. Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: An international epidemiological investigation. J Intern Med 2006;260:245-254
39. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149: 242-250
40. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-716
41. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
42. Schleithoff SS, Zittermann A, Stuttgen B, et al. Low serum levels of intact osteocalcin in patients with congestive heart failure. J Bone Miner Metab 2003;21:247-252
43. Muchmore JS, Cooper DK, Ye Y, et al. Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991;23:1184-1185